The Pandemic

COVID-19 Pandemic Coverage

March 2022

• SARS-CoV-2: Where Did It Come From, and Where Does It Go Next? Mar. 7. (Mara Aspinall)

February 2022

• When Does COVID Normalcy Begin? Feb. 24. (Larry Corey)
• The Omicron Story: The Winter of Our Discontent. Feb. 9. (Larry Corey)

January 2022

• The Omicron Wave: A Review of the Research on Spread and Severity. Jan. 6. (Mara Aspinall)

December 2021

• A Doctor’s View From the Front Line of the Omicron Wave. Dec. 30. (Alex Harding)
• Controlling COVID: Masks, Treatments & Fast, Frequent Testing. Dec. 20. (Mara Aspinall)
• The Long War. Dec. 15. (Otello Stampacchia)
• Vaccines Must Produce Antibody and T cell Immunity. Dec. 14. (Harlan Robins)

November 2021

• Omicron Variant: The Latest Pandemic Twist. Nov. 26. (Otello Stampacchia)

August 2021

• Vaccination and the Delta Variant: 4 Steps Forward, 2 Steps Back. Aug. 16. (Larry Corey)

July 2021

• Why We Need mRNA Vaccines in Africa. July 20. (Larry Corey)
• From Delta…to Omega? July 19. (Otello Stampacchia)

June 2021

• T-cell Immunity Analysis Wasn’t Practical at Scale Before COVID. Now It Is. June 10. (Chad Robins)

May 2021

• RT-PCR Tests Have Quantitative Power for COVID-19. Let’s Use It. May 3. (Mara Aspinall)

April 2021

• Rare Side Effects in Adenoviral Vaccines Calls for Careful Surveillance. Apr. 28. (Larry Corey)
• COVID-19 Testing: Going to the Dogs? Apr. 5. (Mara Aspinall and Genie Joseph)

March 2021

• Flying Blind on the Origin of the Pandemic. Mar. 29. (Ruth Etzioni)
• AZ Tells Us Vaccine is OK. Rebuilding Trust Will Take a While. Mar. 22. (Luke Timmerman)
• AZ’s Vaccine Mess. Mar. 16. (Luke Timmerman)
• One Vaccine Dose or Two? We Need Our Best Defenses. Mar. 14. (Larry Corey)
• Once Vaccinated, What To Do With Masks? Mar. 10. (Larry Corey)
• J&J Vaccine: One Dose Delivers Strong Immune Response and Protection. Mar. 3. (Larry Corey)

February 2021

• Pfizer / BioNTech Ace Real-World Vaccine Tests. Feb. 25. (Luke Timmerman)
• Comprehensive Policy Against Infection: There’s No Better Time. Feb. 24. (Ankit Mahadevia)
• Increasing Vaccine Confidence With Tools That Got Us This Far. Feb. 16. (Michele Andrasik)
• Long COVID’s Insidious Toll. Feb. 12. (Luke Timmerman)
• The Variants Ratchet Up the Pressure. Feb. 7. (Mara Aspinall)
• Scientists Love Data — And Data Show Most People Love Anecdotes. Feb. 5. (David Shaywitz)
• The Insurrectionist and the Visionary. Feb. 4. (Luke Timmerman)
• The Rise of the Variants. Feb. 1. (Otello Stampacchia)

January 2021

• The Evolving Virus Against Vaccines. Jan. 31. (Larry Corey)
• Ideas for an FDA Reboot. Jan. 28. (Luke Timmerman)
• A Bold Idea for the NIH. Jan. 21. (Luke Timmerman)
• Two Doses or One? Let’s Stick to the Data. Jan. 17. (Chris Beyrer and Larry Corey)
• How Worried Should We Be About Emerging Strains? Jan. 14. (Mara Aspinall)
• Biotech is Radiant at a Dark Moment. Jan. 8. (Luke Timmerman)
• The Vaccine Rollout Could Prompt Real Reform to the US Health System. Jan. 5. (Alex Harding)

December

• Listening Through the Noise and Talking to Those Who Will Listen. Dec. 22. (Sam Blackman)
• Science in the Face of Fear: Vaccine Hesitancy and Public Trust. Dec. 20. (Larry Corey)
• There Is Light, But It’s a Long Tunnel. Dec. 19. (Otello Stampacchia)
• A Triumph of the Scientific Enterprise. Dec. 17. (Luke Timmerman)
• A Grateful Physician Reflects on Getting the Vaccine. Dec. 17. (Amanda Banks Christini)
• Round 2: What’s Changed, and What Hasn’t in COVID-19 Treatment. Dec. 17. (Alex Harding)
• The Vaccine Is Coming. Scientists Need to Stay Focused on Equity. Dec. 11. (Michele Andrasik)
• Pfizer, BioNTech Gets Advisory OK. Now Comes the Hard Work. Dec. 10. (Luke Timmerman)
• Vaccine Communication: An Opportunity for Biopharma to Lead. Dec. 10. (Kyle Serikawa)
• Vaccine Trials: A Band of Brothers and Sisters. Dec. 7. (Larry Corey)
• This COVID-19 Long Hauler is Still Trying to Recover. Dec. 7 (E. Blair Clark-Schoeb)
• AZ’s Muddy Result. Dec. 3. (Luke Timmerman)
• Vaccine Scarcity: Buckle Up for Debate. Dec. 1. (Larry Corey)
• COVID Drives Development of At-Home Diagnostics. Dec. 1. (Frank Vinluan)

November

• The Weather Outside is Frightful, and That’s Only the Half of It. Nov. 30. (Lisa Suennen)
• Why I Volunteered for a Vaccine Trial. Nov. 25. (Mike Huckman)
• Getting Married in 2020. Nov. 24. (Carolyn Ng)
• A New Model for Vaccine Communications. Nov. 23. (Mike Kuczkowski)
• Why Operation Warp Speed Studies Weren’t Limited to Severe Disease. Nov. 20. (Larry Corey)
• The mRNA Vaccine News is Good. But Let’s Keep the Masks for Now. Nov. 18. (Larry Corey)
• Pfizer, BioNTech’s Vaccine Watershed. Nov. 12. (Luke Timmerman)

October

• What Happened in Switzerland? Oct. 29. (Alex Mayweg)
• How Many COVID-19 Deaths Could Have Been Avoided? Oct. 27. (Ruth Etzioni)
• Getting Ready for the Next Pandemic. Oct. 19. (Ankit Mahadevia)
• Learning from COVID-19: Lessons for Real World Data. Oct. 7. (David Shaywitz)
• Seeing COVID-19 in Spatial Context. Oct. 7. (Sarah Warren & Jason Reeves)

September

• COVID-19 Testing Needs to Be Open, Not Closed. Sept. 30. (Alex Dickinson)
• What We Know and What We Don’t. Sept. 21. (Alex Harding)
• Moderna & Pfizer Transparency & a Tribute to Bill Gates Sr. Sept. 17. (Luke Timmerman)
• Industry and Academia Take a Stand for Science. Sept. 10 (Luke Timmerman)
• FDA and CDC Credibility Tarnished; Pfizer Sprints Ahead With Vaccine. Sept. 3. (Luke Timmerman)

August

• Prepare for a Difficult Fall. Aug. 31. (Otello Stampacchia)
• A Swing and a Miss From the CDC. Aug. 28. (Mike Pellini)
• Convalescent Plasma: Look Before You Leap. Aug. 27. (Ruth Etzioni)
• COVID-19 Is Driving a Shift in How We Value Diagnostic Tests. Aug. 6. (Bonnie Anderson)

July

• Pfizer Secures $2B for Vaccine Work & Our Test. July 23. (Luke Timmerman)
• Standing With Tony Fauci. July 16. (Luke Timmerman)
• Do We Need Models Anymore? July 15. (Ruth Etzioni)
• The Remdesivir Pricing Letter That Gilead Should Have Written. July 10. (Peter Kolchinsky)
• Novavax Nabs $1.6B, and a Tribute to Dr. Fauci. July 9. (Luke Timmerman)

June

• Q&A With Regeneron on Neutralizing Antibodies. June 29. (KJ Mulam)
• How the US is Losing Against the Virus. June 26. (Otello Stampacchia)
• The Exponential Curves Re-Emerge. June 26. (Luke Timmerman)
• Inconvenient Truths and Rays of Light. June 11. (Luke Timmerman)
• Making Drugs at the Edge of Reason. June 10. (Vicki Sato)
• Anger, Pain and Hope. June 4. (Luke Timmerman)
• Puretech Focuses on Long-Term Lung Complications in COVID19 Patients. June 2. (KJ Mulam)
• Dig Deep and Fight Hard Against Injustice. June 1. (Rob Perez)

May

• The Infodemic Summer. May 28. (Luke Timmerman)
• The Long Recovery. May 27. (Dr. Alex Harding)
• Miscommunication, Mishandled Policy & Misunderstood Liberty. May 26. (Otello Stampacchia)
• A Glimmer of Hope, and a Premature Celebration. May 21. (Luke Timmerman)
• Creating Leaner and Meaner Clinical Trials. May 21. (Pam Tenaerts)
• Getting the Numbers Wrong. May 19. (Ruth Etzioni)
• Doctors on the Tension Between Individual Autonomy and Systems. May 19. (David Shaywitz)
• Stepping Up the Pandemic Humor. May 19. (Lisa Suennen)
• Meet My Friend Who Supported Trump in 2016. May 15. (Luke Timmerman)
• Vaccine Strategy. Larry Corey on The Long Run. May 13. (Luke Timmerman)
• Science in Plain English for the Pandemic. May 11. (Luke Timmerman)
• Keeping the Faith and Bracing for the Long Slog. May 7. (Luke Timmerman)
• Randomized Controlled Trials Work. Let’s Do More. May 7. (David Shaywitz)
• Extending an Immune Medicine Platform Against the Common Foe. May 6. (Chad Robins)
• Giving Models, and Modelers, a Bad Name. May 5. (Ruth Etzioni)
• The Spirit of Giving Is More Powerful Than Ever. May 5. (Kelly O’Brien)
• We Can Better Fight Drug-Resistant Bacteria. May 4. (Vidya Atluri & Paul Pottinger)
• A Time for Empathy. May 1. (Luke Timmerman)

April

• Tracking Viral Outbreaks. Emma Hodcroft on The Long Run. Apr. 30. (Luke Timmerman)
• Keeping an Academic Lab Afloat. Apr. 28. (Jim Olson)
• We Didn’t Become the World Biotech Leader By Sealing Ourselves Off. Apr. 28. (Bernat Olle)
• Capturing Family History, While We Have Time. Apr. 27. (Leora Schiff)
• How a Gesture Morphed Into a Full-Time Effort to Feed the Frontline. Apr. 27. (Ellen Kuwana)
• A San Francisco Doctor Answers the Call to NYC. Apr. 25. (Ethan Weiss)
• A Sad Week of Reckless Leadership. Apr. 24. (Luke Timmerman)
• Build Back Better. Apr. 22. (David Shaywitz)
• Massachusetts Biotechs Consider How to Return Safely. Apr. 22. (Adam Thomas)
• How to Navigate a Blizzard of Antibody Studies. Apr. 21. (Ruth Etzioni)
• Singapore Forgot to Check Its Blind Spot. Apr. 21. (Carolyn Ng)
• Cultivating a Tolerance for Adversity in Our Teams. Apr. 20. (Eric Murphy)
• The Real Question is How to Restart. Apr. 17. (Otello Stampacchia)
• Walking the Diagnostic and Serologic Testing Tightrope. Apr. 17. (Ruth Etzioni)
• Hunting for Antibodies: George Scangos on The Long Run. Apr. 17 (Luke Timmerman)
• Bridging the Social Divide in the Pandemic. Apr. 17. (Dr. Alex Harding)
• Serology Testing: Keep an Eye Out for Quick-and-Dirty Tests. Apr. 16. (Michael Koeris)
• Scaling Up Antibodies and Vaccines Won’t Be Easy. Apr. 16. (Jim Thomas)
• Don’t Waste This Crisis: Solving the Patient Cost-Share Problem. Apr. 15. (Jeff Berkowitz)
• Drug Repurposing to Keep COVID19 Patients Out of the ICU. Apr. 15. (Robert Plenge)
• A Healthcare Investor, and Doctor, Peering into the Fog. Apr. 14. (David Sable)
• The Pandemic Takes a Certain Kind of Toll on African Americans. Apr. 14. (Stephen Graham)
• Why COVID-19 Can’t Be Compared With Flu. Apr. 14. (Ruth Etzioni)
• The Testing Fiasco Continues. Apr. 9. (Luke Timmerman)
• Facing the Consequences of a Misinformation Pandemic. Apr. 8. (Kyle Serikawa)
• Rationale for Testing Anticoagulants Against COVID19. Apr. 7. (Ethan Weiss)
• Not All COVID-19 Models Are Created Equal. Apr. 7. (Ruth Etzioni)
• I’ve Got a Fund Full of Toilet Paper and I’m Ready to Deal. Apr. 6. (Lisa Suennen)
• Where the Puck is Going: Serologic Testing. Apr. 6 (Michael Koeris)
• Loss & Grief During Covid19. Apr. 6. (Dr. Katherine Shear, Laurel Mayer & Jeff Lieberman)
• Diagnostic Dysfunction: Mike Pellini on The Long Run. Apr. 4. (Luke Timmerman)
• A Baffling Coronavirus Response. Frontpoints. Apr. 2. (Luke Timmerman)
• A Chance at Redemption for US Healthcare. Apr. 2. (Leora Schiff)
• Thinking Ahead: Building a Broad Arsenal Against Infectious Disease. Apr. 1. (Ankit Mahadevia)
• Building on Our Immunology Understanding, Seeing Reasons for Hope. Apr. 1. (Doug Williams)
• What’s the Real Risk of Death from COVID19? Apr. 1. (Otello Stampacchia)

March

• Learning From China, Ramping Up Testing to Meet the Need. Mar. 31. (Kristi Heim)
• Switzerland: What Went Right, and How to Prepare for the 2nd Wave. Mar. 31. (Alex Mayweg)
• COVID19 Teaches Us the Real Definition of a Novel Drug. Mar. 29. (Peter Kolchinsky)
• As the Virus Comes to India, Expect Generic Drug Shortages. Mar. 29. (Bruce Carter)
• Knowledge is Power. Don’t Give Up on Testing. Mar. 28. (Mike Pellini)
• Singapore: Braving the Second Wave of COVID19. Mar. 27. (Carolyn Ng)
• Do’s and Don’ts of Videoconferencing. Mar. 27. (Nina Kjellson)
• The Seattle Scientific Community, Mobilized. Mar. 27. (Kristin Anderson)
• The Coronavirus Tsunami. Mar. 26. (Luke Timmerman)
• Watch Pharmacies After Coronavirus. Mar. 26. (Jeff Berkowitz)
• We Interrupt This Nightmare to Bring You a Few Giggles. Mar. 26 (Lisa Suennen)
• Unsung Heroes Who Give Me Hope. Mar. 25. (Bob More)
• Gratitude From A Doctor on the Front Lines in Boston. Mar. 25 (Dr. Alex Harding)
• What Not to Do. Lessons From Spain. Mar. 24. (Bernat Olle)
• Doctor, Mother, CEO: Balancing Demands, Choosing the Front Line. Mar. 24. (Dr. Amanda Banks Christini)
• Digital Tools Find Opportunity in Clinical Trials. Mar. 24 (David Shaywitz)
• Let it Rip or Shelter at Home? Mar. 23. (Otello Stampacchia)
• Staying Mentally Healthy in the Crisis. Mar. 23. (Dr. Jeff Lieberman & Dr. Laurel Mayer)
• Why Telehealth Companies Are Worried About Trust. Mar. 22. (David Shaywitz)
• Love in the Time of Coronavirus. Mar. 21. (Julie Sunderland)
• It Takes A Global Village. Mar. 20. (Praveen Tipirneni)
• Biotech Can Help the Most Vulnerable. Mar. 20. (Rob Perez)
• The Response Roadmap Not Followed. Mar. 19. (Leora Schiff)
• Singapore: What We Can Learn from a High-Risk Country. Mar. 19 (Carolyn Ng)
• The Biopharmaceutical Counterattack. Mar. 19. (Jeremy Levin)
• Eight Days Later. Italy vs. US. Mar. 18. (Otello Stampacchia)
• Dangerous Shortages of Equipment. A Nurse’s View. Mar. 17. (Luke Timmerman)
• Life on the Front Lines of a Pandemic. Mar. 14. (Dr. Alex Harding)
• Covid-19: Collective Problem-Solving Time. Mar. 12. (Luke Timmerman)
• Lessons From Italy: How the US Can Respond to Urgent Threat. Mar. 10. (Otello Stampacchia)
• Covid-19 Spreads in Seattle. Mar. 5. (Luke Timmerman)

February

• Gilead, Moderna Rise to the Occasion. Feb. 27. (Luke Timmerman)
• Coronavirus Fog. Feb. 6. (Luke Timmerman)

January

• Coronavirus Fear Spreads. Jan. 30. (Luke Timmerman)
• Much Ado About Coronavirus. Jan. 23. (Luke Timmerman)